First Opinion By Joe Lieberman and Michelle McMurry-Heath Russian aggression underscores the U.S.’s need for greater investment in medical countermeasures
Hospitals By Tara Bannow Life or death decisions and no feedback: New study highlights the value of patient tracking, especially in the ER
Pharmalot By Ed Silverman Two dozen states side with HHS in its raucous dispute with pharma over a drug discount program
Biotech By Allison DeAngelis Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences